Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lassa virus nucleoprotein (NP) is a multifunctional protein essential for the Lassa virus life cycle. It encapsidates the viral RNA genome, participates in replication and transcription, suppresses host innate immunity by degrading dsRNA, and is involved in viral assembly. NP is a key therapeutic target due to its critical role in viral pathogenesis and its unique structural features.
Inhibition of nucleoprotein function would disrupt viral replication, transcription, and immune evasion. Potential mechanisms include blocking RNA binding, inhibiting exonuclease activity, or disrupting protein-protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lassa Virus Nucleoprotein (NP).